|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||17.03 - 18.03|
|52 Week Range||14.36 - 28.36|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 01, 2023 - Mar 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||29.50|
AUSTIN, Texas, November 07, 2022--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 4th Annual Wolfe Research Healthcare Conference including a fireside chat presentation on Thursday, November 17 at 1:20 PM Eastern Time.
Agilon (AGL) delivered earnings and revenue surprises of -40% and 6.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
AUSTIN, Texas, November 03, 2022--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the third quarter ended September 30, 2022.